Companies/Insmed Incorporated

Company profile

Insmed Incorporated

NASDAQ: INSM · Healthcare · Biotechnology

PublicHQ Bridgewater, NJCIK 0001104506Reports USD

#195 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

66B

FH 48DQ 80GM 78SS 90

v0.1 · 65/100 weight · provisional

↑ market scale, workforce scale · ↓ return on equity, operating margin

Methodology →

Revenue TTM

$819.6M

Rev growth YoY (TTM)

+115.1%

Net income (FY)

-$1.3B

Employees

1,271

Market cap

$24.2B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$606.4M$606.4M2025

Net income-$1.3B-$1.3B2025

Operating income-$1.2B-$1.2B2025

Total assets$2.3B$2.3B2025

Liabilities$1.5B$1.5B2025

Equity$739.0M$739.0M2025

Revenue trend

FY2019 – FY2025 · USD

$38.9M

FY19

$136.5M

FY19

$164.4M

FY20

$188.5M

FY21

$245.4M

FY22

$305.2M

FY23

$363.7M

FY24

$606.4M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Reportable100%

By geography

UNITED STATES75%

Non-US25%

The read

Insmed Incorporated booked $606.4M in FY2025 revenue, growing 67% year over year — faster than most Healthcare companies we track, at a -210.5% net margin.

Peers · Healthcare

Quest Diagnostics Incorporated88A Waters Corporation81B+United Therapeutics Corporation92A Labcorp Holdings Inc.83B+

Key facts

CEOWilliam H. Lewis

SectorHealthcare

IndustryBiotechnology

HeadquartersBridgewater, NJ

ExchangeNASDAQ: INSM

Employees1,271

IPO date2000-06-01

Latest filings

8-K2026-05-15 10-Q2026-05-07 8-K2026-05-07 8-K2026-04-07 DEF 14A2026-04-01 8-K2026-03-23 8-K2026-02-19 10-K2026-02-19

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.